9-99218425-A-G

Variant summary

Our verdict is Benign. The variant received -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BS1BS2

The NM_033087.4(ALG2):​c.760T>C​(p.Leu254Leu) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00491 in 1,614,186 control chromosomes in the GnomAD database, including 30 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).

Frequency

Genomes: 𝑓 0.0040 ( 2 hom., cov: 33)
Exomes 𝑓: 0.0050 ( 28 hom. )

Consequence

ALG2
NM_033087.4 synonymous

Scores

2

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:6

Conservation

PhyloP100: 1.16

Publications

2 publications found
Variant links:
Genes affected
ALG2 (HGNC:23159): (ALG2 alpha-1,3/1,6-mannosyltransferase) This gene encodes a member of the glycosyltransferase 1 family. The encoded protein acts as an alpha 1,3 mannosyltransferase, mannosylating Man(2)GlcNAc(2)-dolichol diphosphate and Man(1)GlcNAc(2)-dolichol diphosphate to form Man(3)GlcNAc(2)-dolichol diphosphate. Defects in this gene have been associated with congenital disorder of glycosylation type Ih (CDG-Ii). Alternative splicing results in multiple transcript variants. [provided by RefSeq, Nov 2008]
ALG2 Gene-Disease associations (from GenCC):
  • congenital myasthenic syndrome 14
    Inheritance: AR Classification: STRONG, MODERATE Submitted by: PanelApp Australia, Labcorp Genetics (formerly Invitae), Genomics England PanelApp
  • ALG2-congenital disorder of glycosylation
    Inheritance: Unknown, AR Classification: STRONG, MODERATE, SUPPORTIVE, LIMITED Submitted by: Labcorp Genetics (formerly Invitae), ClinGen, G2P, PanelApp Australia, Orphanet, Ambry Genetics
  • congenital myasthenic syndromes with glycosylation defect
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -21 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.81).
BP6
Variant 9-99218425-A-G is Benign according to our data. Variant chr9-99218425-A-G is described in ClinVar as Benign/Likely_benign. ClinVar VariationId is 96238.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=1.16 with no splicing effect.
BS1
Variant frequency is greater than expected in population nfe. GnomAd4 allele frequency = 0.00396 (603/152292) while in subpopulation NFE AF = 0.00697 (474/68022). AF 95% confidence interval is 0.00645. There are 2 homozygotes in GnomAd4. There are 281 alleles in the male GnomAd4 subpopulation. Median coverage is 33. This position passed quality control check.
BS2
High Homozygotes in GnomAd4 at 2 AR,Unknown gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
ALG2NM_033087.4 linkc.760T>C p.Leu254Leu synonymous_variant Exon 2 of 2 ENST00000476832.2 NP_149078.1 Q9H553-1A0A024R184
ALG2XM_047423996.1 linkc.481T>C p.Leu161Leu synonymous_variant Exon 2 of 2 XP_047279952.1
ALG2NR_024532.2 linkn.967T>C non_coding_transcript_exon_variant Exon 3 of 3

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
ALG2ENST00000476832.2 linkc.760T>C p.Leu254Leu synonymous_variant Exon 2 of 2 1 NM_033087.4 ENSP00000417764.1 Q9H553-1
ALG2ENST00000319033.7 linkc.481T>C p.Leu161Leu synonymous_variant Exon 2 of 2 1 ENSP00000326609.6 Q9H553-2
ALG2ENST00000238477.5 linkn.*502T>C non_coding_transcript_exon_variant Exon 3 of 3 2 ENSP00000432675.2 A0A0A0MTE0
ALG2ENST00000238477.5 linkn.*502T>C 3_prime_UTR_variant Exon 3 of 3 2 ENSP00000432675.2 A0A0A0MTE0

Frequencies

GnomAD3 genomes
AF:
0.00396
AC:
603
AN:
152174
Hom.:
2
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.000603
Gnomad AMI
AF:
0.00329
Gnomad AMR
AF:
0.00340
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.000829
Gnomad FIN
AF:
0.00395
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.00697
Gnomad OTH
AF:
0.00143
GnomAD2 exomes
AF:
0.00396
AC:
995
AN:
251486
AF XY:
0.00402
show subpopulations
Gnomad AFR exome
AF:
0.000677
Gnomad AMR exome
AF:
0.00176
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00333
Gnomad NFE exome
AF:
0.00705
Gnomad OTH exome
AF:
0.00407
GnomAD4 exome
AF:
0.00501
AC:
7326
AN:
1461894
Hom.:
28
Cov.:
31
AF XY:
0.00497
AC XY:
3615
AN XY:
727248
show subpopulations
African (AFR)
AF:
0.000657
AC:
22
AN:
33480
American (AMR)
AF:
0.00161
AC:
72
AN:
44724
Ashkenazi Jewish (ASJ)
AF:
0.000268
AC:
7
AN:
26136
East Asian (EAS)
AF:
0.00
AC:
0
AN:
39700
South Asian (SAS)
AF:
0.000962
AC:
83
AN:
86258
European-Finnish (FIN)
AF:
0.00451
AC:
241
AN:
53420
Middle Eastern (MID)
AF:
0.000693
AC:
4
AN:
5768
European-Non Finnish (NFE)
AF:
0.00600
AC:
6670
AN:
1112012
Other (OTH)
AF:
0.00376
AC:
227
AN:
60396
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.483
Heterozygous variant carriers
0
484
968
1451
1935
2419
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
226
452
678
904
1130
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00396
AC:
603
AN:
152292
Hom.:
2
Cov.:
33
AF XY:
0.00377
AC XY:
281
AN XY:
74476
show subpopulations
African (AFR)
AF:
0.000602
AC:
25
AN:
41556
American (AMR)
AF:
0.00340
AC:
52
AN:
15294
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3468
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5192
South Asian (SAS)
AF:
0.000830
AC:
4
AN:
4820
European-Finnish (FIN)
AF:
0.00395
AC:
42
AN:
10620
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
0.00697
AC:
474
AN:
68022
Other (OTH)
AF:
0.00142
AC:
3
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.499
Heterozygous variant carriers
0
30
61
91
122
152
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
10
20
30
40
50
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00348
Hom.:
2
Bravo
AF:
0.00341
EpiCase
AF:
0.00692
EpiControl
AF:
0.00522

ClinVar

Significance: Benign/Likely benign
Submissions summary: Benign:6
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:3
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Jan 12, 2021
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Feb 01, 2025
CeGaT Center for Human Genetics Tuebingen
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

ALG2: BP4, BP7, BS2 -

ALG2-congenital disorder of glycosylation;C4015597:Congenital myasthenic syndrome 14 Benign:2
Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Nov 03, 2021
Fulgent Genetics, Fulgent Genetics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

not specified Benign:1
Jan 12, 2018
Eurofins Ntd Llc (ga)
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.81
CADD
Benign
2.5
DANN
Benign
0.57
PhyloP100
1.2
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.1
Mutation Taster
=100/0
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs62562374; hg19: chr9-101980707; API